Search research articles
Contact Us
Filters
Showing results (61-70 of 176) with videos related to
Page
of 18
Sort By:
Journal for Immunotherapy of Cancer
|
March 15, 2019
Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy
Cristiane Decat Bergerot, Paulo Gustavo Bergerot, Errol J Philip, et al.
Clinical Genitourinary Cancer
|
March 15, 2018
Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate Cancer
Manish K Thakur, Lance Heilbrun, Kimberlee Dobson, et al.
Cancer Immunology, Immunotherapy : CII
|
June 10, 2019
An HER2 DNA vaccine with evolution-selected amino acid substitutions reveals a fundamental principle for cancer vaccine formulation in HER2 transgenic mice
Richard F Jones, Joyce D Reyes, Heather M Gibson, et al.
Urology
|
September 17, 2015
Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium Study
Ulka Vaishampayan, Daniel Shevrin, Mark Stein, et al.
Experimental Hematology & Oncology
|
October 14, 2017
Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study
Jennifer Brown, Ruth Plummer, Todd M Bauer, et al.
Biomaterials
|
September 5, 2018
Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages
Hashem O Alsaab, Samaresh Sau, Rami M Alzhrani, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2004
Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer
Edgar Ben-Josef, Anthony F Shields, Ulka Vaishampayan, et al.
Investigational New Drugs
|
August 6, 2022
Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors
Xiaofei Zhou, Ulka Vaishampayan, Devalingam Mahalingam, et al.
The Journal of Urology
|
January 22, 2008
Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer
Judah Friedman, Rodney L Dunn, David Wood, et al.
Cancer Immunology Research
|
February 26, 2015
Induction of HER2 Immunity in Outbred Domestic Cats by DNA Electrovaccination
Heather M Gibson, Jesse J Veenstra, Richard Jones, et al.
Page
of 18
Search research articles
Search
Showing results (61-70 of 176) with videos related to
Sort By:
Page
of 18
Journal for Immunotherapy of Cancer
|
March 15, 2019
Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy
Cristiane Decat Bergerot, Paulo Gustavo Bergerot, Errol J Philip, et al.
Clinical Genitourinary Cancer
|
March 15, 2018
Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate Cancer
Manish K Thakur, Lance Heilbrun, Kimberlee Dobson, et al.
Cancer Immunology, Immunotherapy : CII
|
June 10, 2019
An HER2 DNA vaccine with evolution-selected amino acid substitutions reveals a fundamental principle for cancer vaccine formulation in HER2 transgenic mice
Richard F Jones, Joyce D Reyes, Heather M Gibson, et al.
Urology
|
September 17, 2015
Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium Study
Ulka Vaishampayan, Daniel Shevrin, Mark Stein, et al.
Experimental Hematology & Oncology
|
October 14, 2017
Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study
Jennifer Brown, Ruth Plummer, Todd M Bauer, et al.
Biomaterials
|
September 5, 2018
Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages
Hashem O Alsaab, Samaresh Sau, Rami M Alzhrani, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2004
Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer
Edgar Ben-Josef, Anthony F Shields, Ulka Vaishampayan, et al.
Investigational New Drugs
|
August 6, 2022
Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors
Xiaofei Zhou, Ulka Vaishampayan, Devalingam Mahalingam, et al.
The Journal of Urology
|
January 22, 2008
Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer
Judah Friedman, Rodney L Dunn, David Wood, et al.
Cancer Immunology Research
|
February 26, 2015
Induction of HER2 Immunity in Outbred Domestic Cats by DNA Electrovaccination
Heather M Gibson, Jesse J Veenstra, Richard Jones, et al.
Page
of 18